Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_assertion type Assertion NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_head.
- NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_assertion description "[PC-3 CM inhibited bone nodule formation and the activity of alkaline phosphatase (ALPase), an osteoblastic marker enzyme, on days 7, 14, and 21 (RC cells) or 3, 6, and 9 (ROS 17/2.8 cells) in a dose-dependent manner (5-30% CM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_provenance.
- NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_assertion evidence source_evidence_literature NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_provenance.
- NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_assertion SIO_000772 9328830 NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_provenance.
- NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_assertion wasDerivedFrom befree-20140225 NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_provenance.
- NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_assertion wasGeneratedBy ECO_0000203 NP484232.RA8vB29GQfcqdbCSf-_WafqAj9Xq63p1vgFANRP9GTTgc130_provenance.